Doltro Injection 30 mg/ml contains Ketorolac Tromethamine 30 mg per ml, a potent non-steroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. Administered via intravenous (IV) or intramuscular (IM) routes, this formulation provides rapid and effective analgesia, making it ideal for conditions such as postoperative pain, musculoskeletal injuries, renal colic, or acute inflammatory pain.
Ketorolac, the active ingredient, works by inhibiting cyclooxygenase (COX) enzymes, which reduces the production of prostaglandins, chemical mediators responsible for pain, inflammation, and fever. Doltro Injection 30 mg/ml provides fast-acting relief, especially in patients who cannot take oral analgesics or require rapid pain management in clinical settings.
This formulation is commonly used in hospitals, emergency departments, and post-surgical units, helping patients achieve effective pain control while reducing reliance on opioids. Its short-term use ensures potent pain relief with a reduced risk of long-term adverse effects.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Doltro Injection 30 mg/ml is indicated for:
Postoperative pain, including orthopedic, dental, or abdominal surgeries
Acute musculoskeletal pain, such as sprains, strains, or back pain
Renal colic pain management
Short-term treatment of moderate to severe acute pain where oral therapy is unsuitable
Provides rapid onset of analgesia for immediate relief
Reduces pain, inflammation, and swelling associated with acute conditions
Non-opioid therapy, reducing the risk of dependence
Suitable for patients unable to take oral NSAIDs
Effective short-term pain control in hospital or emergency settings
Ketorolac Tromethamine is a non-selective COX-1 and COX-2 inhibitor. COX enzymes are responsible for the synthesis of prostaglandins, which mediate pain, inflammation, and fever.
Analgesic effect: Reduces pain by blocking prostaglandin-mediated stimulation of nerve endings.
Anti-inflammatory effect: Decreases inflammation by limiting prostaglandin-induced vasodilation and fluid accumulation.
Antipyretic effect: Helps lower fever by modulating hypothalamic prostaglandin activity.
By targeting these pathways, Doltro Injection provides fast and effective relief from acute pain and inflammation.
Adults: 30 mg per ml via IM or IV injection, depending on clinical need.
Maximum recommended dose: 120 mg per day, administered in divided doses every 6 hours.
IV administration: Inject slowly over 15–30 seconds to minimize local irritation.
IM administration: Inject into a large muscle mass (gluteal or thigh).
Therapy should not exceed 5 days due to potential adverse effects with prolonged use.
Contraindicated in patients with active gastrointestinal bleeding, peptic ulcers, renal failure, or hypersensitivity to NSAIDs.
Avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids unless prescribed.
Use cautiously in elderly patients, those with cardiovascular disease, or impaired liver/kidney function.
Not recommended during late pregnancy due to fetal risk.
Monitor for gastrointestinal bleeding, renal dysfunction, and allergic reactions during therapy.
Doltro Injection 30 mg/ml is generally well tolerated. Side effects may include:
Injection site irritation or pain
Nausea, heartburn, or gastrointestinal discomfort
Headache or dizziness
Rarely, gastrointestinal bleeding, renal dysfunction, or allergic reactions
Most side effects are mild and transient, resolving with dose adjustment or discontinuation.
Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children. Use single-use vials only once and discard any remaining solution.
Login Or Registerto submit your questions to seller
No none asked to seller yet